CP55,940 increases intracellular Ca2+ levels in Madin-Darby canine kidney cells

Life Sci. 2001 Aug 17;69(13):1541-8. doi: 10.1016/s0024-3205(01)01242-5.

Abstract

The effect of CP55,940, a presumed CB1/CB2 cannabinoid receptor agonist, on intracellular free Ca2+ levels ([Ca2+]i) in Madin-Darby canine kidney cells was examined by using the fluorescent dye fura-2 as a Ca2+ indicator. CP55,940 (2-50 microM) increased [Ca2+]i concentration-dependently with an EC50 of 8 microM. The [Ca2+]i signal comprised an initial rise and a sustained phase. Extracellular Ca2+ removal decreased the maximum [Ca2+]i signals by 32+/-12%. CP55,940 (20 microM)-induced [Ca2+]i signal was not altered by 5 microM of two cannabinoid receptor antagonists, AM-251 and AM-281. CP55,940 (20 microM)-induced [Ca2+]i increase in Ca2+-free medium was inhibited by 86+/-3% by pretreatment with 1 microM thapsigargin, an endoplasmic reticulum Ca2+ pump inhibitor. Conversely, pretreatment with 20 microM CP55,940 in Ca2+-free medium for 6 min abolished thapsigargin-induced [Ca2+]i increases. CP55,940 (20 microM)-induced intracellular Ca2+ release was not inhibited when inositol 1,4,5-trisphosphate formation was abolished by suppressing phospholipase C with 2 microM U73122. Collectively, this study shows that CP,55940 induced significant [Ca2+]i increases in canine renal tubular cells by releasing stored Ca2+ from the thapsigargin-sensitive pools in an inositol 1,4,5-trisphosphate-independent manner, and also by causing extracellular Ca2+ entry. The CP55,940's action appears to be dissociated from stimulation of cannabinoid receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism*
  • Cannabinoids / pharmacology*
  • Cell Line
  • Cyclohexanols / pharmacology*
  • Dogs
  • Estrenes / pharmacology
  • Extracellular Space / metabolism
  • Indicators and Reagents
  • Inositol 1,4,5-Trisphosphate / antagonists & inhibitors
  • Inositol 1,4,5-Trisphosphate / biosynthesis
  • Kidney / cytology
  • Kidney / metabolism*
  • Morpholines / pharmacology
  • Piperidines / pharmacology
  • Pyrazoles / pharmacology
  • Pyrrolidinones / pharmacology
  • Receptors, Cannabinoid
  • Receptors, Drug / agonists*
  • Receptors, Drug / antagonists & inhibitors

Substances

  • Cannabinoids
  • Cyclohexanols
  • Estrenes
  • Indicators and Reagents
  • Morpholines
  • Piperidines
  • Pyrazoles
  • Pyrrolidinones
  • Receptors, Cannabinoid
  • Receptors, Drug
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • AM 251
  • 3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol
  • Inositol 1,4,5-Trisphosphate
  • AM 281
  • Calcium